Synthetic androgens and hGH are anabolic mechanisms with several FDA approved drugs, but have concerning safety risks.1 Newer anabolic drugs rely on newer mechanisms that can avoid these safety risks
Currently, there is no genetic cure for Systemic Primary Carnitine Deficiency (SPCD), which is also sometimes called OCTN2 deficiency or Carnitine Transporter Deficiency [1] [2] [3]
When used under medical supervision, injectable GHK-Cu is well-tolerated with a strong safety profile
20 mg bottle $199 BPC 157 Gut and Tissue Repair BPC-157 promotes rapid healing of the gut lining, muscles, tendons, and ligaments, making it highly effective for treating injuries, ulcers, and inflammatory conditions
Where These Numbers Come From Cagrilintide has a robust clinical trial program with published phase 2 and phase 3 data
I started Retatrutide in late May